Who owns ERAS?
Institutional ownership of Erasca Inc. from Form 13F, Q2 2026
257 institutional managers reported holding Erasca Inc. (ERAS) in Form 13F filings for Q2 2026, with 281,177,119 shares worth $5.1B. The largest reported holder was Frazier Life Sciences Management, L.P. Managers that filed both quarters added a net 11,002,164 shares (+4.1%). 58 opened new positions and 27 sold out.
- Funds holding
- 257
- Value held
- $5.1B
- New / sold out
- 58 / 27
- Net shares, same filers
- +4.1%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ERAS
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $458M | 8.9% | 24,975,188 | Added |
| T. Rowe Price Investment Management, Inc. | $388M | 7.5% | 21,185,839 | Trimmed |
| BlackRock, Inc. | $388M | 7.5% | 21,154,146 | Added |
| RTW Investments, LP | $329M | 6.4% | 17,946,754 | Added |
| Venrock Adviser, LLC | $328M | 6.4% | 17,891,812 | Added |
| State Street Corp | $223M | 4.3% | 12,184,555 | Added |
| Logos Global Management LP | $223M | 4.3% | 12,150,000 | Added |
| Vanguard Capital Management LLC | $209M | 4.1% | 11,402,199 | Added |
| Siren, L.L.C. | $209M | 4.1% | 11,397,781 | Added |
| Paradigm Biocapital Advisors LP | $175M | 3.4% | 9,550,000 | Trimmed |
| ARCH Venture Management, LLC | $130M | 2.5% | 7,091,557 | Unchanged |
| Geode Capital Management, LLC | $119M | 2.3% | 6,501,426 | Added |
| Price T Rowe Associates Inc | $115M | 2.2% | 6,272,508 | Added |
| Cormorant Asset Management, LP | $110M | 2.1% | 6,000,000 | Added |
| Affinity Asset Advisors, LLC | $96.2M | 1.9% | 5,250,000 | Trimmed |
| Vivo Capital, LLC | $75.6M | 1.5% | 4,127,412 | Trimmed |
| Goldman Sachs Group Inc | $70.0M | 1.4% | 3,822,113 | Trimmed |
| Alliancebernstein L.p. | $66.6M | 1.5% | 4,118,614 | Added |
| Bank of America Corp | $55.9M | 1.1% | 3,048,737 | Trimmed |
| FMR LLC | $52.8M | 1.0% | 2,883,417 | Added |
| a16z Capital Management, L.L.C. | $52.4M | 1.0% | 2,862,500 | Unchanged |
| Woodline Partners LP | $51.9M | 1.0% | 2,831,867 | Unchanged |
| Jennison Associates LLC | $51.1M | 1.0% | 2,788,412 | New |
| Soleus Capital Management, L.P. | $49.5M | 1.0% | 2,700,000 | New |
| Vanguard Portfolio Management LLC | $43.8M | 0.8% | 2,389,864 | Added |
Share of 13F holdings is each fund's shares as a share of the 281,177,119 ERAS shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Price T Rowe Associates Inc Added+$81.7M
- State Street Corp Added+$52.8M
- Jennison Associates LLC New+$51.1M
- Soleus Capital Management, L.P. New+$49.5M
- Samlyn Capital, LLC New+$41.3M
- RTW Investments, LP Added+$32.8M
- Assenagon Asset Management S.A. New+$29.8M
- Venrock Adviser, LLC Added+$27.6M
- FMR LLC Added+$25.5M
- Evergreen Quality Fund GP, Ltd. New+$25.2M
Biggest sellers in Q2 2026
- Vivo Capital, LLC Trimmed-$147M
- Balyasny Asset Management L.P. Trimmed-$82.2M
- 5AM Venture Management, LLC Sold out-$56.4M
- Montanova Capital, LLC Sold out-$55.6M
- Commodore Capital LP Sold out-$51.4M
- Adage Capital Partners GP, L.l.c. Sold out-$34.0M
- Goldman Sachs Group Inc Trimmed-$19.3M
- Paradigm Biocapital Advisors LP Trimmed-$15.4M
- Holocene Advisors, LP Trimmed-$11.6M
- Silverarc Capital Management, LLC Trimmed-$10.8M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $833M and sold $607M; 101 added and 75 trimmed.
Schedule 13D and 13G filings on ERAS
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-05-15RTW INVESTMENTS, LP SCHEDULE 13G filed by Erasca Inc.Schedule 13G
- 2025-08-14SUVRETTA CAPITAL MANAGEMENT, LLC SCHEDULE 13G filed by Erasca Inc.Schedule 13G
Questions about ERAS ownership
- Who owns ERAS stock?
- 257 institutional investment managers reported ERAS positions in their Form 13F filings for Q2 2026, holding 281,177,119 shares worth $5.1B in total. Frazier Life Sciences Management, L.P. reported the largest position.
- Are funds buying or selling ERAS?
- In Q2 2026, 58 managers opened new ERAS positions, 101 added, 75 trimmed and 27 sold out. Managers that filed in both quarters added a net 11,002,164 shares.
- How current is this ERAS institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ERAS by CUSIP. Options are left out. ERAS news and filings · ERAS insider trades · Top funds